Evidence map›Paper›PMID 35098926›Full record

ArticleeLife2022

Pathogen infection and cholesterol deficiency activate the

Nicholas D Peterson, Janneke D Icso, J Elizabeth Salisbury, Tomás Rodríguez, Paul R Thompson, Read Pukkila-Worley

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Frontiers in tuberculosis · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Regulation of TIR-1/SARM-1 by miR-71 Protects Dopaminergic Neurons in aInternational journal of molecular sciences · 2024
    Article
  19. Modeling Host-Pathogen Interactions inInternational journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nicholas D Peterson *Program in Innate Immunity, Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, United States.ORCID 0000-0003-4157-8119
Janneke D Icso *Program in Chemical Biology, University of Massachusetts Chan Medical School, Worcester, United States.
J Elizabeth SalisburyProgram in Innate Immunity, Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, United States.
Tomás RodríguezRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, United States.ORCID 0000-0002-8724-5427
Paul R ThompsonProgram in Chemical Biology, University of Massachusetts Chan Medical School, Worcester, United States.ORCID 0000-0002-1621-3372
Read Pukkila-WorleyProgram in Innate Immunity, Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, United States.ORCID 0000-0001-5340-8294
University of Massachusetts Chan Medical School · US

Funding

Chemical probes to decipher PAD biologyR35GM118112 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Paul R Thompson · 2016 to 2026
$9.5M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Medical Scientist Training at UMMS Administrative SupplementT32GM107000 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIEFE, CATARINA I. · 2013 to 2022
$4.9M
An Immune Surveillance Network in C. elegansR01AI130289 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PUKKILA-WORLEY, READ · 2017 to 2025
$4.6M
Sensing bacterial patterns of pathogenesis by an enzymatic TIR proteinR01AI159159 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Read Pukkila-Worley · 2021 to 2026
$3.7M
Training in the Molecular Basis of Autoimmunity and AutoinflammationT32AI132152 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Katherine A. Fitzgerald, Ann Marshak-Rothstein · 2018 to 2026
$1.6M
Neuroendocrine regulation of intestinal epithelial immunity in C. elegansR21AI163430 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PUKKILA-WORLEY, READ · 2021 to 2022
$461k
Pathogen sensing by nuclear hormone receptors in C. elegans intestinal epithelial cellsF30AI150127 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PETERSON, NICHOLAS · 2020 to 2023
$132k
Investigating the Activation Mechanism of SARM1 during Axon DegenerationF31NS122423 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DOEDEE, JANNEKE · 2021 to 2023
$97k
NIAID NIH HHS F30 AI150127NIAID NIH HHS R01 AI130289NIAID NIH HHS R01 AI159159NIAID NIH HHS R21 AI163430NIAID NIH HHS T32 AI132152NIGMS NIH HHS R35 GM118112NIGMS NIH HHS T32 GM107000NIH HHS P40 OD010440NINDS NIH HHS F31 NS122423
6 · The paper itself

Abstract

Intracellular signaling regulators can be concentrated into membrane-free, higher ordered protein assemblies to initiate protective responses during stress - a process known as phase transition. Here, we show that a phase transition of the

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsAnimalsCholesterolMammalsNADNAD+ NucleosidaseCaenorhabditis elegans ProteinsCholesterolNADNAD+ Nucleosidasecaenorhabditis eleganscholesterolimmunologyinfectious diseaseinflammationintestinal epithelial immunitymicrobiologyp38 pathwayphase transitionpseudomonas aeruginosaTIR-1/SARM1

Identifiers

PMID35098926
PMCPMC8923663
OpenAlexW4210298079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.